by | Apr 25, 2024 | Publications
J Hematol Oncol. 2024 Apr 24;17(1):23. doi: 10.1186/s13045-024-01530-z. ABSTRACT BACKGROUND: The autologous anti-B-cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T-cell therapy LCAR-B38M has been approved for the treatment of relapsed and refractory...
by | Apr 25, 2024 | Publications
Front Oncol. 2024 Apr 10;14:1394048. doi: 10.3389/fonc.2024.1394048. eCollection 2024. ABSTRACT Patients with relapsed/refractory multiple myeloma (RRMM) that are refractory to the five most active anti-MM drugs, so-called penta-refractory MM, have historically had...
by | Apr 25, 2024 | Publications
JAAD Case Rep. 2024 Mar 16;47:84-86. doi: 10.1016/j.jdcr.2023.12.024. eCollection 2024 May. NO ABSTRACT PMID:38659473 | PMC:PMC11039776 | DOI:10.1016/j.jdcr.2023.12.024
by | Apr 25, 2024 | Publications
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Apr;32(2):483-492. doi: 10.19746/j.cnki.issn.1009-2137.2024.02.025. ABSTRACT OBJECTIVE: To investigate the clinical efficacy and safety of ixazomib-containing regimens in the treatment of patients with multiple myeloma (MM)....
by | Apr 25, 2024 | Publications
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Apr;32(2):493-498. doi: 10.19746/j.cnki.issn.1009-2137.2024.02.026. ABSTRACT OBJECTIVE: To investigate the relationship between clinical indicators of CRAB symptoms and antioxidant enzyme activity in patients with multiple...
by | Apr 25, 2024 | Publications
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Apr;32(2):499-504. doi: 10.19746/j.cnki.issn.1009-2137.2024.02.027. ABSTRACT OBJECTIVE: To analyze the prognostic nutritional index (PNI), controlling nutritional status (CONUT) and fibrinogen/albumin ratio (FAR) levels in...
